PET Imaging as a Tool for Assessing COVID-19 Brain Changes

Trends Neurosci. 2020 Dec;43(12):935-938. doi: 10.1016/j.tins.2020.10.010. Epub 2020 Oct 22.

Abstract

A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection.

Keywords: PET radiotracers; SARS-CoV-2; neurological manifestations.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Brain / diagnostic imaging*
  • Brain / metabolism
  • Brain / pathology
  • COVID-19 / complications
  • COVID-19 / diagnostic imaging*
  • COVID-19 / physiopathology
  • Humans
  • Neuroimaging / methods*
  • Positron-Emission Tomography / methods*